Arthrex ACP® Naturally Better.
Autologous Conditioned Plasma (ACP) for skin rejuvenation and treatment of alopecia
Arthrex ACP® Naturally Better.
Autologous Conditioned Plasma (ACP) for skin rejuvenation and treatment of alopecia
Arthrex
Arthrex is the global market leader for PRP/PRF systems and has been distributing its high-quality medical products for over 10 years in fields such as aesthetic medicine, dermatology, orthopedics, and plastic surgery.
Other innovative products and techniques, such as the ACA technique for harvesting microfat and stromal vascular fraction (SVF), in addition to our unique training programs, help Arthrex to achieve its mission of Helping Surgeons Treat Their Patients Better.
More than 18,000 medical devices
28 Subsidiaries
6 Wetlabs
More than 6000 employees
Arthrex ACP Double Syringe
Safe and Simple Preparation of Platelet-Rich Plasma Without Anticoagulant
Double syringe – closed system, made in Germany.
Intuitive preparation – fast, safe and easy.
Autologous – no anticoagulants, no separation gel.
Minimal injection pain
Optimized composition – rich in fibrinogen 2.5-fold platelet concentration, independently verified.
Natural treatment – uses body’s own regeneration.
Demonstrated clinical efficacy – (> 100 studies / FDA-sanctioned level-1 study)
Personalised Cell Therapy
Fast, Well Tolerated, Using Only the Body’s Own Substances
Acknowledged and Effective
The Arthrex ACP Double Syringe System is the world’s leading medical device for preparation of PRP. Innovative PRP systems from Arthrex enable easy production of proven, effective PRPs and platelet-rich fibrin (PRF) gels without having to compromise on safety and quality:
-
- Highly effective – a PRP tailored to the indication.
- High level of safety – closed and needle-free systems to prevent infections and needlestick injuries.
- Easy to use – intuitive / automated processes to prevent incorrect use.
- High quality and reliable – established systems from a market-leading company.
1. Personalised | From One’s Own Body
Out of 15 cc body’s own blood, 5 to 6 cc of PRP is prepared using the Arthrex ACP Double Syringe.
2. Cell Therapy | PRP
The PRP is injected at the treatment site (e.g., face and hairline) to stimulate the body’s own regeneration processes.
Treatment Process
Convenient for Both the User and the Patient
Arthrex Personalized Cell Therapy is a PRP (platelet-rich plasma) procedure that harnesses the body’s own healing and regeneration processes.
By injecting endogenous PRP at the treatment site, healing and regeneration of tissue can be stimulated on a purely natural basis.
This takes place through a range of growth factors and signaling molecules that occur in platelets and blood plasma. The interaction with corresponding receptors in the target cells, for example fibroblasts, mesenchymal stem cells, and epidermal cells, initiates processes that lead to cell proliferation, collagen synthesis, and matrix formation, among other things.
-
-
Withdrawal of a small quantity of blood
-
A separation procedure extracts and concentrates the body’s own active substances
-
Injection / application of these active substances at the treatment site
-
Stimulation of hyaluronic acid and collagen synthesis, cell proliferation, and regeneration processes
-
BECOME A PROVIDER
If you are interested in administering the highest quality ACP services to your patients, contact the official distributor of Arthrex Personalized Cell Therapy in Southern Africa, NuAngle Medical by clicking on the button below.
References
- Aust M et al. Platelet-rich Plasma for Skin Rejuvenation and Treatment of Actinic Elastosis in the Lower Eyelid Area. Cureus. 2018 Jul 18;10(7):e2999.
- Graziani F et al. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res. 2006 Apr;17(2):212-9.
- Wang X et al. Behavior of Gingival Fibroblasts on Titanium Implant Surfaces in Combination with either Injectable-PRF or PRP. Int J Mol Sci. 2017 Feb 4;18(2). pii: E331.
- Loibl M et al. The effect of leukocyte-reduced platelet-rich plasma on the proliferation of autologous adipose-tissue derived mesenchymal stem cells. Clin Hemorheol Microcirc. 2016;61(4):599-614.
- Magalon J et al. Product analysis: PRP. IMCAS World Congress, Paris, France. 2017, 2018, 2019, 2020.
- Smith PA. Intra-articular Autologous Conditioned Plasma Injections Provide Safe and Efficacious Treatment for Knee Osteoarthritis: An FDA-Sanctioned, Randomized, Double-blind, Placebo-controlled Clinical Trial. Am J Sports Med. 2016 Apr;44(4):884-91.